FMF: No Cases of Kidney Amyloidosis
16 January 2024

 

Pediatrician Sergey Sargsyan, the head of the Institute of Children and Adolescent Health at the "Arabkir" Medical Complex, addressed questions from the Public Television Company "News" regarding Periodic disease / Familial Mediterranean Fever (FMF), a genetic condition prevalent among Armenians and relatively common in our population.


Thanks to the dispensary control service established decades ago, cases of complications related to the disease and its consequential kidney failure have significantly decreased from 16% to 0 among children under the age of 18 with FMF.

 

Approximately 3600 children diagnosed with FMF are currently undergoing treatment in Armenia, including compatriots under the age of 18 residing in other countries with the same diagnosis. The doctor emphasizes that approximately 400 children receive this diagnosis annually, with a noticeable upward trend in recent years.
 

According to pediatrician Sergey Sargsyan, the head of the “Arabkir” Medical Center-ICAH “Periodic disease” is a hereditary disorder. Although some may refer to it as the “Yerevanian disease”, it is unrelated to the city of Yerevan. In the international classification, it is known as “familial Mediterranean fever”, affecting people from this region, including Armenians, Sephardic Jews, Arabs, and Turks, who naturally inherited the gene through centuries of mixing with different populations.

 

The disease can manifest with recurrent fever, abdominal pain, and may even lead to kidney failure. It is prevalent among the Armenian population, with most cases developing before the age of 20, depending on the type of gene.

 

Dr. Sargsyan explains, “One in five individuals has one gene, but a single gene is insufficient. For the disease to develop, two genes—maternal and paternal—must combine, in most cases.”

 

While in the 1990s, approximately 16% of children in our country experienced kidney complications before reaching adulthood, the current scenario has changed. 

 

Sargsyan details, “The discovery of the gene, conducted by the Center of Genetics in Armenia, along with subsequent organizational efforts and the implementation of a unique ambassadorial model, where patients visit the center for treatment and check-ups, has led to a remarkable reduction. Today, I can report that the initial 16% has decreased a hundredfold. We now have unique cases where children develop kidney complications, at least in infancy.

 

The Children's Republican Center for Periodic Diseases at the “Arabkir” Medical Center provides treatment for children aged 0-18 years under the state order.


Sergey Sargsyan adds, “People over the age of 18 can also receive appropriate medication and undergo monitoring at the regional health center.

Various treatment and control models are available. The crucial aspect is to diagnose the disease promptly and at its earliest stage.

Share on Facebook
Last news
Years of Tireless Work Recognized by the WHO
Years of Tireless Work Recognized by the WHO   The World Health Organization (WHO) has officially designated Arabkir Medical Center-Institute of Child and Adolescent Health (Arabkir MC-ICAH) as a “WHO Collaborating Centre” in the field of child and adolescent health. This recognition places Armenia among an elite group of nine countries in the WHO European Region, including Great Britain, France, Switzerland, Germany, Italy, Ireland, Norway, and Russia.     An event was held today at "Arabkir" BH-ICAH to celebrate this milestone. Distinguished attendees included Minister of Health Anahit Avanesyan, Deputy Minister Armen Gasparyan, Head of the WHO Armenia Office Siddhartha Datta, UN Resident Coordinator Françoise Jacquet, and representatives from UNICEF, UNFPA, the UN World Food Program, and other local and international organizations.     Professor Ara Babloyan, Scientific Director of Arabkir MC-ICAH, welcomed guests, expressing gratitude for their presence on this significant occasion. Reflecting on the institute’s journey since its establishment in 2003, he noted initial skepticism about its purpose. However, the institute's accomplishments have had a profound impact not only in Armenia but also internationally. These efforts, focused on child development, adolescent health, school health, and pediatric care quality, have earned the trust and recognition of the WHO. Arabkir MC-ICAH continues to lead transformative programs in alignment with Armenia's Ministry of Health strategies, contributing to improved health outcomes for children and adolescents.     Sergey Sargsyan, Head of the Institute of Child and Adolescent Health, presented the Institute's activities across various domains, ranging from educational, research, and informational programs to practical medicine. Special emphasis was placed on rehabilitation, newborn screening, rapid response initiatives, and training for nurses and allied health professionals. Notably, one of the most recent achievements is that just a few days ago, the European Council of Pediatrics granted the Arabkir MC-ICAH the status of a pediatric allergology training center meeting European standards.     The attendees were also greeted and congratulated via videoconference by Martin Weber, Head of the Child and Adolescent Health Program at the WHO European Office, who is responsible for quality assurance in medical care.     Siddhartha Datta, Head of the WHO Armenia Office, expressed high appreciation for the work of Arabkir MC-ICAH over the years. He remarked on numerous occasions where he was deeply impressed by the center’s exceptional contributions, which have consistently demonstrated a level of excellence. This outstanding work, he noted, served as the basis for the WHO granting such a prestigious status at the regional level. In his speech, Dr. Datta emphasized the center’s extensive expertise in child and adolescent health, disease prevention, and treatment, as well as its data-driven, research-oriented approaches. He added that such centers of excellence, with their significant achievements and accumulated experience, have the potential to receive recognition as WHO Collaborating Centers, which opens doors for broader collaboration and even greater success.     Minister Anahit Avanesyan, in her speech, described the occasion as historic and of great public and state significance. She stated: "We are proud that this center is the first in Armenia to receive the status of a WHO Collaborating Center. Despite limited resources, our country continuously expands programs aimed at preserving, restoring, and improving the health of children and adolescents. This policy remains a priority."     Upon receiving the document confirming the WHO Collaborating Center status, Ara Babloyan expressed his gratitude, stating: "We are happy to not only learn from the world’s leading health organizations but also share our knowledge and experience with other countries. This is the formula for humanity's progress."